Literature DB >> 20700739

Current status of sentinel lymph-node biopsy in patients with breast cancer.

Gang Cheng1, Stephanie Kurita, Drew A Torigian, Abass Alavi.   

Abstract

Axillary node status is the most important prognostic indicator for patients with invasive breast cancer. Sentinel lymph-node biopsy (SLNB) is widely accepted and the preferred procedure for identifying lymph-node metastasis. SLNB allows focused excision and pathological examination of the most likely axillary lymph nodes to receive tumor metastases while avoiding morbidities associated with complete axillary nodal dissection. Since its introduction in the early 1990s, the process of SLNB has undergone continual modification and refinement; however, the procedure varies between institutions and controversies remain. In this review, we examine the technical issues that influence the success of lymph node mapping, discuss the controversies, and summarize the indications and contraindications for axillary node mapping and biopsy in clinical practice.

Entities:  

Mesh：

Year:  2010        PMID： 20700739     DOI： 10.1007/s00259-010-1577-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  132 in total

1.  Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer.

Authors:  C Lanng; J Hoffmann; H Galatius; U Engel
Journal:  Eur J Surg Oncol       Date:  2006-11-03       Impact factor: 4.424

2.  Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.

Authors:  Angie R Taras; Nyle A Hendrickson; Kimberly A Lowe; Mary Atwood; J David Beatty
Journal:  Am J Surg       Date:  2010-05       Impact factor: 2.565

3.  Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.

Authors:  Stephen P Povoski; Johannes O Olsen; Donn C Young; Johannah Clarke; William E Burak; Michael J Walker; William E Carson; Lisa D Yee; Doreen M Agnese; Rodney V Pozderac; Nathan C Hall; William B Farrar
Journal:  Ann Surg Oncol       Date:  2006-09-07       Impact factor: 5.344

4.  Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.

Authors:  Giovanni D'Eredita'; Carmela Giardina; Giuseppe Ingravallo; Giuseppe Rubini; Vincenzo Lattanzio; Tommaso Berardi
Journal:  Breast       Date:  2007-02-09       Impact factor: 4.380

5.  Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.

Authors:  Igor Langer; Walter Richard Marti; Ulrich Guller; Holger Moch; Felix Harder; Daniel Oertli; Markus Zuber
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

6.  Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

Authors:  Jean-François Rodier; Michel Velten; Marc Wilt; Pierre Martel; Gwanaël Ferron; Véronique Vaini-Elies; Hervé Mignotte; Alain Brémond; Jean-Marc Classe; François Dravet; Thierry Routiot; Christine Tunon de Lara; Antoine Avril; Gérard Lorimier; Eric Fondrinier; Gilles Houvenaeghel; Sandrine Avigdor
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

7.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

Authors:  Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Gladys L Giron; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

8.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.

Authors:  Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

9.  Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.

Authors:  Jeryong Kim; Jinsun Lee; Eilsung Chang; Seongmin Kim; Kwangsun Suh; Jiyoung Sul; Insang Song; Yonghoon Kim; Chuljoo Lee
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

10.  Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma.

Authors:  James W Horvath; Gary E Barnett; Rafael E Jimenez; Donn C Young; Stephen P Povoski
Journal:  World J Surg Oncol       Date:  2009-03-24       Impact factor: 2.754
View more
  18 in total

1.  A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients.

Authors:  Dipasree Som; Megha Tak; Mohit Setia; Asawari Patil; Amit Sengupta; C Murali Krishna Chilakapati; Anurag Srivastava; Vani Parmar; Nita Nair; Rajiv Sarin; R Badwe
Journal:  Lasers Med Sci       Date:  2015-11-09       Impact factor: 3.161

2.  Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Authors:  Lene Rask; Eva Balslev; Rolf Søkilde; Estrid Høgdall; Henrik Flyger; Jens Eriksen; Thomas Litman
Journal:  Cell Oncol (Dordr)       Date:  2014-07-16       Impact factor: 6.730

Review 3.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

4.  Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis.

Authors:  Abass Alavi; Sean D Carlin; Thomas J Werner; Abdullah Al-Zaghal
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  Sentinel Lymph Node Biopsy in Patients with Breast Cancer: Comparison of Peritumoral and Periareolar Injection.

Authors:  T Rosenow; C Biedendieck; H Fricke; M Brinkmann; U Cirkel; W-D Reinbold; E Fricke
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-11       Impact factor: 2.915

6.  Tumor-induced alterations in lymph node lymph drainage identified by contrast-enhanced MRI.

Authors:  Alanna Ruddell; Sara B Kirschbaum; Sheila N Ganti; Cheng-Liang Liu; Ryan R Sun; Savannah C Partridge
Journal:  J Magn Reson Imaging       Date:  2014-09-25       Impact factor: 4.813

7.  SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.

Authors:  Amparo Garcia-Burillo; Isabel Roca Bielsa; Oscar Gonzalez; Carles Zafon; Monica Sabate; Josep Castellvi; Xavier Serres; Carmela Iglesias; Ramon Vilallonga; Enric Caubet; Jose Manuel Fort; Jordi Mesa; Manuel Armengol; Joan Castell-Conesa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-02       Impact factor: 9.236

Review 8.  Light in and sound out: emerging translational strategies for photoacoustic imaging.

Authors:  S Zackrisson; S M W Y van de Ven; S S Gambhir
Journal:  Cancer Res       Date:  2014-02-10       Impact factor: 12.701

9.  The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Authors:  Francesco Giammarile; Naomi Alazraki; John N Aarsvold; Riccardo A Audisio; Edwin Glass; Sandra F Grant; Jolanta Kunikowska; Marjut Leidenius; Valeria M Moncayo; Roger F Uren; Wim J G Oyen; Renato A Valdés Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

Review 10.  MicroRNAs as therapeutic targets in breast cancer metastasis.

Authors:  Fahima Danesh Pouya; Yousef Rasmi; Maria Gazouli; Eleni Zografos; Mohadeseh Nemati
Journal:  Drug Deliv Transl Res       Date:  2021-05-13       Impact factor: 4.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.